no way cd12 mortality reduction is 63%. if it was even as good as 50% CD12 would have been stopped for efficacy at the interim.
I am hoping for 33% mortality reduction but covid treatment has been chaos for the entire time of CD12.
Anything could happen.
(2)
(0)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-